IL1A and hydrops fetalis: The pharmacological targeting of the IL-1 cascadehas also shown excellent protective effects in experimental animal models.Although the potential efficacy of IL-1 targeting in HF patients still needs tobe confirmed in large clinical trials, there is considerable evidence that IL-1may have a cardioprotective effect.